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Abstract
Background: The treatment of elderly patients with Kashin-Beck disease (KBD) remains clinically challenging, and
clinical data are very lacking. The aim of this study was to retrospectively evaluate pain and functional outcomes
following total hip replacement in adult patients with severe KBD of the hip.
Methods: Twenty-two patients (32 hips) with KBD underwent primary hip replacement and were followed for at
least 2 years. Radiographic and Clinical assessments were evaluated for each patient at 2 and 4 weeks and at 3, 6
and 12 months after the operation and annually thereafter. The efficacy index included the visual analogue scale
(VAS) score, Harris hip score, functional score for adult Tibetans with Kashin-Beck Disease (FSAT-KBD) and
radiographic outcomes.
Results: The patients underwent a follow-up, and the mean follow-up time was 3.8 years. VAS scores significantly
decreased within the first 6 months postoperatively. This decrease continued until the final follow-up (p < 0.01). This
result was supported by a significant increase in the Harris and FSAT-KBD scores after the surgery (p < 0.01). At the
final follow-up, there was no change in prosthesis positioning or radiographic evidence of prosthesis loosening.
One case received impacted allograft bone croutons and had worn polyethylene components replaced after
6 years because the patient suffered severe pelvic and femoral osteolytic lesions postoperatively.
Conclusions: Hip replacement can relieve pain and improve joint function in treating severe KBD hip. Additional
studies that are more extensive are needed to confirm the findings of our study.
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Background
Kashin-Beck disease (KBD) is an endemic, chronic,
osteoarticular disease that mainly occurs in China, Siberia
and North Korea [1]. A recent study showed that there
are more than 695,000 patients with KBD and that 105.84
million people are at risk for KBD in the endemic area of
China [2]. KBD usually afflicts children between the ages
of 3 and 12 years and becomes symptomatic in adults [3].
Although KBD has been studied for more than 100 years,
little is known about its etiology. The current suspected
causes mainly involve cereal contamination by mycotoxin-
producing fungi, trace element nutritional deficiencies
(selenium and iodine), high levels of fulvic acid in drinking
water and harsh physical environments in the endemic
areas [4–9].
The basic pathological feature of KBD is focal chon-
drocyte necrosis in multiple areas of hyaline cartilage,
including articular cartilage and growth plates. The sec-
ondary pathological findings of KBD are the presence of
repair and remodeling around the necrotic foci of the
cartilage of the metaphysic and epiphysis, which can re-
sult in growth retardation, secondary degradation of
cartilage and disability in the advanced stages of the dis-
ease, similar to that in osteoarthritis (OA) [10–12].
The clinical symptoms of KBD include pain in mul-
tiple joints, shortened and enlarged fingers and de-
formed joints involving limited activity in the end of the
joints and leading to a high proportion of advanced-
stage disability [13, 14] (Fig. 1). Pain and limited func-
tion of the hip are primary factors that affect the quality
of life and functionality in elderly KBD patients [14].
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Presently, no effective clinical measures can repair the
cartilage damage or defects caused by KBD. Most treat-
ment methods are derived from experience with OA
treatment. The administration of non-steroidal anti-
inflammatory drugs (NSAIDs), intra-articular injections
of hyaluronic acid and physical therapy could reduce
knee pain and/or improve knee joint function for elderly
KBD patients prior to the advanced stage of KBD. How-
ever, these treatments do little to improve joint function
and do not achieve long-term efficacy in end-stage KBD
knee joints [15–18]. Moreover, only minimal data are
available regarding improving the function of the hips in
patients with severe KBD, especially when their hips
have progressed to deformity.
Total hip replacement is a surgical procedure that has
been shown to be very successful in relieving pain and
physical functionality in older patients with advanced
hip osteoarthritis (OA). In the United States, approxi-
mately 200,000 people receive total hip replacement
every year [19], and that number is projected to increase
to no less than 500,000 in 2030 [20, 21]. The Swedish
Hip Arthroplasty Register reported that the 10-year sur-
vival rate of total hip replacement reached 96 % in both
2000 and 2002. In several studies, a 100 % survival rate
has been achieved [22]. Few studies have reported
clinical results in the treatment of late-stage KBD
patients with total hip replacement. In this study, we
retrospectively determined the effectiveness of total hip
replacement for treating advanced hip disease (Kellgren-
Lawrence (K-L) radiographic grade IV) in adult KBD
patients and provided clinical data for the treatment of
hip KBD in the future [23].
Methods
This study was conducted at the Department of Ortho-
pedics of West China Hospital of Sichuan University
and was approved by the internal research administra-
tion department and ethics committee in accordance
with the Helsinki Declaration. All the patients provided
informed consent prior to enrollment in the study.
Patients were included if they had been symptomatic
for no less than 6 months before enrollment, had experi-
enced pain of more than 60 mm on a 100-mm visual
analogue pain scale (VAS; 0 mm representing no pain
and 100 mm representing the worst imaginable pain) in
the target hip joint during assessment of the patient
while walking, could not walk on a level floor for more
than 200 m because of pain in the target hip, and had a
K-L radiographic grade of more than III in the target hip
[23]. Patients were excluded from the study for any un-
stable medical condition from a total hip replacement
for the treatment of OA, such as inflammation, infection
and abnormal vital signs.
Fig. 1 X-rays display the multiple joints affected in an elderly patient with end-stage KBD: a shoulder, b elbow, c wrist and fingers, d hip,
e knee and f ankle
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At the time of screening, the medical history of each
patient was recorded. A complete physical examination,
particularly focused on the target hip and other affected
joints, and laboratory assessments were performed. A
radiograph of the target hip was also taken. Clinical
diagnoses of KBD were made based on previously de-
scribed clinical criteria by at least two senior orthopedic
surgeons from the Orthopedics Department at the West
China Hospital, West China Medical School, Sichuan
University [11, 24].
Between 2007 and 2012, 22 patients who met the in-
clusion criteria underwent 32 primary total hip replace-
ments in our department and were followed for more
than 2 years. All operations were performed by the
same group of surgeons. All of the patients were from
Aba Prefecture, China, where a recent study reported
that the mean incidence rate of KBD among adults is
41.0 % [25]. Table 1 presents the detailed data for these
22 cases in our study.
Surgical procedure
All total hip replacements were performed on the diseased
hips by the same surgeons in laminar flow operating
rooms. The patients received prophylactic antibiotics,
namely, one dose (2.0 g) of intravenous cefazolin adminis-
tered half an hour before the operation.
An appropriate implant was chosen via the preopera-
tive use of templates, and a routine posterolateral ap-
proach was adopted. Vitalock cups were stabilized via a
line-to-line reaming technique, and Duraloc cups were
inserted via the press-fit technique.
All total hip replacements were performed using cement-
less implants. Small acetabular cups (cup size ≤ 46mm) were
placed in 13 hips after the deepening of the patient’s acetabu-
lum. Six cups were reinforced using screws (4 hips with 2
screw and 2 hips with 3 screws). A morselized autogenous
bone graft (resected from the femoral head) was used to fill
cystic acetabular lesions and screw holes. Trochanteric oste-
otomies were used in the 3 hips in the high-dislocation
group, and subtrochanteric osteotomies were used in the
remaining 1 patient in the high-dislocation group.
Among the 22 patients, 10 patients with bilateral hip
joint involvement underwent surgery for staged total hip
replacements that were performed at an interval of ap-
proximately 7 days. Six patients with severe ipsilateral
knee damage received total hip replacement first,
followed by total knee replacement approximately 7 days
later.
Postoperative treatment
Postoperatively, one dose of prophylactic intravenous
antibiotic (cefazolin, 2.0 g) was administered routinely.
All the patients were administered an intramuscular in-
jection of pethidine and/or oral NSAIDs to relieve post-
surgery pain. All the patients received a nadroparin
calcium injection to prevent venous thrombosis. Quadri-
ceps, gluteal and hamstring setting exercises were
started on the first postoperative day. The patients were
encouraged to walk on the second postoperative day
under the guidance of a physical therapist.
Postoperative evaluations
All the patients received follow-up clinical and radio-
graphic assessments at 2 and 4 weeks and at 3, 6 and
12 months after surgery and annually thereafter. During
each follow-up, all the radiographic and clinical efficacy
measures were evaluated at the outpatient clinics. The
patients reported the clinical efficacy assessments,
whereas the surgeon analyzed the radiographic results.
The outcomes of the clinical measures included com-
plications during the perioperative period and VAS,
Harris score [26], Functional Score for Adult Tibetans
with Kashin-Beck Disease (FSAT-KBD) [27] and radio-
graphic outcomes at every follow-up. The FSAT-KBD
scale is developed by orthopedic experts in our depart-
ment for the specific lifestyles of Tibetans. It was verified
as a reliable, validated tool for the evaluation of improve-
ments in KBD symptoms and function in Tibetans [28].
Postoperative radiographs were reviewed for evidence
of prosthetic loosening according to the criteria of
DeLee et al. and De Ranieri et al. [29, 30]. Cup and stem
loosening or migration was measured between consecu-
tive images using software on our hospital computer
(Syngo Imaging V31, Siemens AG Medical Solutions,
Germany). Normally, acetabular components were con-
sidered to be loosened if they had tilted by more than 5°
in the abduction angle, migrated 2 mm or more or
Table 1 KBD patients characteristics (n = 22, 32 hips)
Clinical manifestation Mean ± SD/ratio
Age, yrs, mean ± SD 52.07 ± 17.46
Sex, M:F 15:7
BMI, kg/m2 23.85 ± 6.76
Side, R: L 18:14
Num of affected big joints 8.15 ± 4.25
KBD Stage, n (%)
Stage I 9 (40.9 %)
Stage II 11 (50.0 %)
Stage III 2 (9.1 %)
Patient-assessed VAS score, mm 72.34 ± 9.16
Investigator-assessed VAS score, mm 71.41 ± 7.21
Harris (0–100) 44.88 ± 6.15
FSAT-KBD score (12–48) 27.69 ± 2.91
KBD Kashin-beck disease, THA total hip arthrosplasty, BMI body mass index, R
right, L left, VAS visual analogue scale pain, FSAT functional score for
adult Tibetans
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presented with a continuous radiolucent line that was
more than 2 mm in width. The cementless femoral com-
ponents were defined as being loosed if serial radio-
graphs showed a progressive axial subsidence greater
than 5 mm or a progressive change in the position of
the femoral component. Osteolysis was defined as a circu-
lar or oval area of distinct bone loss and was graded as
mild (< 1 cm2), moderate (1–1.9 cm2), or severe (> 2 cm2)
on anteroposterior radiographs of the hips.
Statistical Analysis
Statistical analyses were undertaken by SPSS 16.0 soft-
ware (SPSS Inc., Chicago, IL, USA). Continuous data are
presented as a mean ± standard deviation (SD). Changes
in VAS, Harris and FSAT-KBD scores were analyzed
using a general linear model and repeated-measures
ANOVA. Multiple comparisons vs. baseline were assessed
according to Dunnett’s T3 method. Comparisons of the
acetabular component angles between the postoperative
results and the final endpoints were analyzed using
apaired-samples t test. A p value less than 0.05 was con-
sidered significant, and a p value less than 0.01 was con-
sidered highly significant for all statistical tests.
Results
The mean follow-up time of the 22 patients (32 hips) who
completed follow-up was 3.8 years (range: 2–7 years). All
patients were followed for at least 2 years in the out-
patient department after their operation. Seventeen
patients (25 hips) were followed successfully in the out-
patient department until their final follow-up. Five
patients (7 hips) were followed via telephone, while the
x-ray films were delivered, because of bad traffic condi-
tions in the local area (a plateau mountain area with
frequent storms in winter and spring).
All of the patients were confirmed to have KBD
based on pathological examinations after the oper-
ation. The main histopathological findings included
multiple focal areas of degeneration and surface fibril-
lation in the articular cartilage, impaired chondrocyte
differentiation (Fig. 2a), loss of articular cartilage,
endochondral ossification and increased subchondral
plate thickness (Fig. 2b).
Perioperative complications
All the patients were required to walk postoperatively in
an average of 2 days (range: 1–3 days). All the patients
recovered uneventfully after surgery except for one 80-
year old patient who developed a lung infection after the
total hip replacement. This patient was treated with ex-
tended antibiotic therapy and encouraged to cough and
breathe deeply. The lung infection was resolved within
1 week, and the patient successfully received a total knee
replacement on the target knee. The patients received
5 days of postoperative care and were then discharged
from the hospital in good health. No wound-healing dis-
orders, wound infections or deep vein thromboses were
recorded.
Clinical efficacy measures
As measured by the VAS, Harris and FSAT-KBD scores,
all the patients obtained a significant reduction in knee
pain scores and a significant improvement in knee func-
tion after receiving total hip replacement (Fig. 3). The
mean VAS score decreased from 72.34 ± 9.16 mm before
surgery to 15.78 ± 4.23 mm at 6 months post-surgery (p <
0.01 vs. baseline), and this decrease was maintained
through the final follow-up when the lowest score was
reached (12.03 ± 2.80 mm, p < 0.01 vs. baseline). The
average Harris score was significantly improved from
44.88 ± 6.15 before surgery to 85.81 ± 5.58 at 6 months
after operation (p < 0.01 vs. baseline) and reached the
highest score of 90.06 ± 4.57 at the final follow-up after
total hip replacement (p < 0.01 vs. baseline). The mean
FSAT-KBD score showed a trend similar to that of the
Fig. 2 The histopathological findings display multiple focal areas of
degeneration and surface fibrillation in the articular cartilage (a),
endochondral ossification and loss of articular cartilage (b)
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Harris score and improved from 27.69 ± 2.91 at baseline
to its peak of 36.81 ± 3.44 (p < 0.01 vs. baseline) at 2 years
after the surgery. It decreased slightly to 36.66 ± 2.95 (p <
0.01 vs. baseline) at the final follow-up.
Radiographic assessment
The postoperative X-rays displayed that all the pros-
thesis components in the targeted hips were fixed well
and were in a good position (Fig. 4).
At the first follow-up examination, the mean abduc-
tion angle of the acetabular component was 44.7° ±2.5°
(range: 36.5–48.0°). At the last follow-up examination,
the mean abductionangle of the acetabular components
was 44.9° ± 2.4° (range: 37.1–48.3°). There was no signifi-
cant difference in the abduction angle of the acetabular
components (P =0.08). No gap was found at the inter-
face between the bone and the acetabular components
on the immediate postoperative radiograph (Fig. 4c). At
the final follow-up, 2 sockets had radiolucent lines less
than 2 mm in zone 1. Acetabular osteolysis was found in
12.5 % (4 hips) of the 32 hips (1 hip had severe osteoly-
sis, 1 hip had moderate osteolysis, and 2 hips had mild
osteolysis). The mean rate of polyethylene liner wear
was 0.18 ± 0.14 mm/y (range: 0–0.24 mm/y).
After the operation, 25 femoral components were
inserted in a neutral position, 4 in a mildly varus pos-
ition, and 3 in a valgus position. At the latest follow-up
examination, none of the femoral components were ob-
served to have asignificant change in their position
(Fig. 4c). Seven hips showed local osteolysis: in zone 1 in
2 hips and in zone 7 in 5 hips. The 3 hips with greater
trochanteric osteotomies all acquired bony union.
One case experienced a severe hip osteolytic lesion
(zone 1) complicated by femoral osteolysis (zone 7)
6 years postoperatively. The patient subsequently suc-
cessfully received impacted allograft bone croutons in
Fig. 3 The VAS, Harris and FSAT-KBD scores for each time point.
*p <0.01 compared with the pre-operation score
Fig. 4 A male patient (bilateral hip with KBD) (a) with scores of 70, 43 and 25 points in the left hip on the VAS, Harris and Fast-KBD scales,
respectively. He received total hip replacement in his left hip (b). Five-and-a-half years after the operation, there was no radiographic evidence of
loosening or changes in component positioning (c), with scores of 10, 91 and 36 on the VAS, Harris and FSAT-KBD scales, respectively
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both the acetabular and femoral sides and had worn
polyethylene components replaced in our department.
Discussion
KBD is a disabling joint disease involving hyaline cartil-
age that typically leads to osteoarticular damage, de-
formity, pain and a severely limited range of activity in
the advanced stages of the disease [31]. Based on our ex-
perience in treating hip patients with OA, we evaluated
the effect of total hip replacement in treating serious
KBD in the hips of adult patients. We found that total
hip replacement could significantly relieve pain and im-
prove the function of the target hip and overall quality
of life. These results were supported by the significantly
decreased VAS scores and the significantly increased
Harris and FSAT-KBD scores 6 months after replace-
ment, suggesting that total hip replacement provides
long-lasting efficacy and treatment of the hip pain and
activity limitations resulting from KBD.
Total hip replacement is a successful surgical proced-
ure that could improve joint function and relieve pain
involving the late stages of hip OA in adult patients.
Good long-term survival has been reported for cemen-
ted and cementless total hip replacement implants in
studies in America [32, 33]. Studies have shown that
most patients achieved good results, with some showing
a 100 % survival rate [22]. All the replacement proce-
dures in our study were performed for the treatment of
serious KBD hip with K-L grade IV. All the patients
obtained good clinical results within 2 years postopera-
tively, and no change in the prosthesis positioning or
radiographic evidence of prosthesis loosening was found
at the last follow-up (range: 2–7 years), which is similar
to the results of the aforementioned reports [22, 32, 33].
Only one case experienced a severe pelvic osteolytic
lesion (zone 1) complicated with femoral osteolysis
(zone 7) at 6 years postoperatively. This patient success-
fully received impacted allograft bone croutons and had
worn polyethylene components replaced.
Few studies have reported clinical results on total hip
replacement treatment in late-stage knee with KBD
cases. Yang et al. reported nine cases of hip with KBD
that included treatment with total hip replacement.
Among these patients, 66.7 % of the patients (four cases)
had good results, and one patient had fair (60–70 points)
results based on the Harris scores [34]. More recently,
Qian GB et al. reported on 13 cases (20 hips) of patients
with KBD that underwent total hip replacement [35].
The 13 cases were divided into two groups based on the
use of cemented or cementless components and were
followed for 8–48 months. The outcomes showed that
all the hips in both groups had good clinical outcomes
according to their Harris scores. No radiographic
evidence of prosthesis loosening, sinkage or change in
prosthesis positioning at the end of the follow-up was
reported. The final averaged Harris score was approxi-
mately 93.0 in these patients, which was similar to the
final scores observed in our study.
KBD typically results in symmetrical and multi-joint
damage in adult patients. Therefore, the function scales
frequently used to evaluate global limb function might
not be appropriate for evaluating the limb function of
the KBD patients in our study because most items in
these existing scoring systems, which have mostly been
designed by Westerners, could be misunderstood and
are confusing to Chinese KBD patients living in Aba
Prefecture, Sichuan province, China. First, Aba Prefec-
ture, where the patients worked, is a very poor moun-
tainous region in China with harsh living conditions on
the Tibetan plateau, known as the roof of the world,
where life predominantly depends on agriculture and
farming [9]. Second, most of the inhabitants in this
epidemic area are Tibetan residents and follow Tibetan
Buddhism, so they have a unique lifestyle and work
habits that are significantly different from Western and
urban residents. For example, the items in the scales de-
signed by Westerners concerning whether one can use a
knife and fork at the dinner table or whether one can sit
on a chair may not be appropriate in this case because
most KBD patients in this area use their right hand to
manipulate food rather than using a knife and fork with
both hands, and they primarily sit on the ground in a
cross-legged position instead of sitting on chairs. The
FSAT-KBD scale has been verified as a validated and re-
liable instrument to assess changes in KBD clinical
symptoms and functional disability in Tibetans [28]. Our
study showed the FSAT-KBD scores improved rapidly
3–6 months after hip replacement, suggesting that total
hip replacement treatment could rapidly improve global
joint function. The slight reduction in the FSAT-KBD
scores after 2 years, relative to the 6-month scores, could
be attributed to the worsening conditions of other limbs
with the passage of the time [14, 27].
Some of the differences between KBD and OA are that
OA usually occurs in elderly people with articular cartil-
age degeneration that is observable via radiology, it sel-
dom affects multiple joints symmetrically and does not
present with shortened fingers and phocomelic limbs. In
contrast, KBD onset often occurs during childhood and
adolescence, symmetrically affects multiple joints and
mainly results in damage to the epiphysis, resulting in
developmental disabilities that are observable via radi-
ology [12]. Therefore, the overall functional results of
KBD patients in the advanced stage are often worse than
those of OA patients because systemic dysfunction may
be aggravated by other large joints involved. KBD pa-
tients who undergo hip replacement often display the
same trend of systemic functional results as time passes,
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which was confirmed in the present study by a slight de-
crease in the FSAT-KBD scores, relative to the 6 month
scores, 2 years after undergoing total hip replacement.
The small number of patients included and the open-
label design could be considered limitations of this
study, which precludes any definitive conclusions re-
garding the effectiveness of total hip replacement treat-
ment in KBD hip cases. We recommend additional
randomized, long-term and prospective studies with
more patients to confirm the findings in this study.
Conclusions
Based on the results of our study, total hip replacement could
be efficacious in treating serious KBD hips with promising
clinical and radiographic outcomes at the intermediate
follow-up period. Additional studies that are of higher quality
are needed to confirm the findings in our study.
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